We learned last week that Apotex Inc., Canada’s largest drug manufacturer, has received approval from Health Canada to market a generic version of Ozempic.
What began as a treatment for diabetes has quickly evolved into something far more consequential – a structural force reshaping consumer behaviour and, by extension, Canada’s agri-food economy. And these drugs will now get cheaper.
